(Reuters) - Quest Diagnostics DGX.N on Thursday raised its full-year revenue and profit forecast, benefiting from growing demand for its non-COVID-19 testing services.
The company said it now expects 2020 profit to be between $7.50 and $9 per share, up from $6.60 to $8.60 per share forecast earlier.
Annual revenue is expected to be between $8.4 billion and $8.8 billion, up from $8 billion to $8.6 billion, it said.
(The story corrects to ‘non-COVID-19 testing services’, from ‘COVID-19 testing services’, in first paragraph)
Reporting by Dania Nadeem in Bengaluru; Editing by Aditya Soni
Our Standards: The Thomson Reuters Trust Principles.